Business
ImmunityBio Inc’s BLA for N-803 Progresses with FDA Submission, Stock Surges
Clinical-stage immunotherapy company, ImmunityBio, announced on Monday the successful resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for...
Markforged Holding Reveals Q3 2023 Financial Results, Adjusts Full-Year Outlook, Stock Declines
Markforged Holding Corporation, a leader in advanced manufacturing technology, released its preliminary financial results for the third quarter (Q3) ended on September 30, 2023. The...
Ascent Solar Technologies Shares Surge on DOE Encouragement
Ascent Solar Technologies witnessed a surge in its shares after receiving a vote of confidence from the U.S. Department of Energy (DOE) to proceed with...
Aerwins Technologies’ Stock Surges 35% Despite Nasdaq Delisting Warning
Aerwins Technologies, a leading player in solar technology, is witnessing a surge in its stock value on Tuesday, despite receiving a delisting notice from the...
Agrify Faces Potential Delisting from Nasdaq Due to Compliance Concerns
Agrify Corporation, a pioneering provider of cutting-edge cultivation and extraction solutions for the cannabis industry, revealed on Friday that it has been notified by The...
From Deficit to Surplus: AC Milan Reports 6.1 Million Euro Profit
After a protracted seventeen-year dry spell, the renowned Italian football institution, AC Milan, has finally turned the tide, reporting a substantial profit for the 2022-23...
NVIDIA Ventures into Personal Computer Market, Challenging Intel’s Longstanding Dominance
NVIDIA, the leading force in Artificial Intelligence computing chips, is gearing up to enter the personal computer market, a domain traditionally ruled by Intel since...
Royal Philips NV Shares Drop 5.3% Amidst Declining Orders and China Probe
Royal Philips NV, a prominent medical-equipment manufacturer, witnessed a significant dip in its shares, plummeting by as much as 5.3% in Amsterdam. This drop in...
Damon Motors Inc. Acquires Inpixon UK: Stock Value Soars in Response
Inpixon announced today a landmark definitive agreement wherein its wholly owned subsidiary, Inpixon Ltd, a division of Inpixon’s statistical analytics and visualization for engineering and...
CEL-SCI Corporation Unveils Multikine Breakthrough in Head and Neck Cancer Treatment, Stock Surges
CEL-SCI Corporation revealed pivotal advancements in its immunotherapy drug Multikine (Leukocyte Interleukin, Injection) for head and neck cancer treatment, during its debut presentation at the...
